Endeavor Clinical Trials

San Antonio, TX

Endeavor Clinical Trials Overview

Principal Investigators
Richard Pollak, DPM, MS
Hernan Salazar, DO, JD, MPH, FAAFP, CCRP – Medical Director

Russell Stanley, DPM
Sherwyn Schwartz, MD

Site Director
Lisa Rodriguez


Post-Operative Pain

  • Bunionectomy
  • Hernia Repair
  • Knee and Hip Arthroscopy
  • Abdominoplasty


  • Diabetic Foot Ulcer
  • Diabetic Neuropathy
  • Gout
  • Type 2 Diabetes
  • Morton’s Neuroma
  • Toenail Fungus (Onychomycosis)
  • Osteoarthritis
  • Plantar Fasciitis
  • Postherpetic Neuralgia
  • Vaccine


  • 5,000 Square Foot Unit
  • Flexible bed space
  • 5 exam rooms
  • Dedicated monitoring space
  • On-site laboratory
  • -20 to -70 Degree Sample Storage
  • 5 miles from international airport

Special Procedures and Equipment
Surgical Procedures
Pulse Oximetry
Diagnostic Ultrasound
Nerve Conduction Monitor
Crash Cart

DaT Scan
CT Scan

Institutional Review Board

For Sponsors and CROs – Please Contact

For Those Interested in Scheduling Screening Visits or Who Are Seeking Site-Specific Information for Clinical Trial Participation, Please Call Endeavor Clinical Trials Directly:

News Feed

March 19, 2018:

Endeavor Clinical Trials Participates in Bringing New Non-Opioid Pain Control Medicine to the Market

ECT was one of the sites that participated in studies investigating a non-opioid postoperative pain medicine. The sponsor, Heron Therapeutics, has announced positive topline results from its completed Phase 3 studies of the investigational agent HTX-011 in subjects undergoing bunionectomy and hernia repair, which achieved all primary and key secondary endpoints in both Phase 3 trials, demonstrating statistically significant reductions in both pain intensity and the use of opioid rescue medications through 72 hours following surgery.

CLICK HERE to read about the positive topline results from the Phase 3 clinical trial.